$49.03 -0.31 (%) Abbott Laboratories - NYSE

May. 22, 2015 | 04:00 PM

Partner Headlines

  1. Making Money With Charles Payne: 05/13/15

    FoxBusiness | May. 13, 2015 | 18:00PM EST
  2. Regeneron, Nike Top Big Cap 20 Stocks Near Buy Points

    IBD | May. 11, 2015 | 19:16PM EST
  3. Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015

    Benzinga | May. 7, 2015 | 17:39PM EST
  4. 8 Dividend Stocks With The Right Qualities

    GuruFocus | Apr. 29, 2015 | 17:32PM EST
  5. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 11:26AM EST
  6. Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds

    IBD | Apr. 24, 2015 | 17:51PM EST
  7. DepoMed Set To Grow On 'Transformative' Nucynta Deal

    IBD | Apr. 23, 2015 | 16:16PM EST
  8. Abbott Labs' Q1 beats views

    IBD | Apr. 22, 2015 | 18:22PM EST
  9. St. Jude, Abbott Labs Beat Q1 Expectations

    IBD | Apr. 22, 2015 | 16:35PM EST
  10. Earnings Beat Propels Abbott Laboratories To New All-Time High

    Benzinga | Apr. 22, 2015 | 13:41PM EST
  11. Abbott Tops Q1 Expectations

    Benzinga | Apr. 22, 2015 | 10:58AM EST
  12. St. Jude, Abbott Labs Beat Q1 Expectations

    IBD | Apr. 22, 2015 | 10:54AM EST
  13. Earnings Scheduled For April 22, 2015

    Benzinga | Apr. 22, 2015 | 04:09AM EST
  14. Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research

    Benzinga | Apr. 20, 2015 | 08:38AM EST
  15. Rosetta Genomics Shares Upgraded At Cantor

    Benzinga | Apr. 17, 2015 | 09:42AM EST
  16. Mylan Q4 Earnings, Guidance In Line As Growth Ramps

    IBD | Mar. 2, 2015 | 17:14PM EST
  17. Making Money With Charles Payne: 02/23/15

    FoxBusiness | Feb. 23, 2015 | 18:00PM EST
  18. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  19. 3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis

    Benzinga | Feb. 23, 2015 | 13:57PM EST
  20. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  21. Mason Hawkins Likes Chemtura, Melco Crown; Doesn't Like Berkshire Hathaway

    Benzinga | Feb. 19, 2015 | 14:59PM EST
  22. AbbVie's Q4 Reflects Its Tremendous Growth Potential Going Forward

    GuruFocus | Feb. 4, 2015 | 11:58AM EST
  23. Mylan Makes Deals In Women's Health, Lung Disease

    IBD | Feb. 2, 2015 | 12:48PM EST
  24. Abbott Launches New Options for People with Cataracts in the United States

    Benzinga | Jan. 30, 2015 | 09:02AM EST
  25. Abbott Laboratories

    IBD | Jan. 29, 2015 | 18:38PM EST
  26. Thermo Fisher, Varian, Abbott Up On Earnings Reports

    IBD | Jan. 29, 2015 | 14:39PM EST
  27. Earnings Scheduled For January 29, 2015

    Benzinga | Jan. 29, 2015 | 04:45AM EST
  28. Feeling Good With This Med Company

    GuruFocus | Jan. 20, 2015 | 15:12PM EST
  29. Nestle & Abbott Labs To Benefit From Chinese Demand For Nutritional Products By Selling Senior-Target Products

    Benzinga | Jan. 20, 2015 | 07:42AM EST
  30. #PreMarket Primer: Friday, December 19: U.S. Debates A Response To Sony Hackers

    Benzinga | Dec. 19, 2014 | 08:17AM EST
  31. Analysts See No Sweeter Deal For Volcano

    Benzinga | Dec. 17, 2014 | 15:34PM EST
  32. Philips Buying Volcano To Boost Image-Guided Therapy

    IBD | Dec. 17, 2014 | 11:34AM EST
  33. US Stock Futures Tumble Ahead Of Producer Prices, Consumer Sentiment Data

    Benzinga | Dec. 12, 2014 | 06:52AM EST
  34. Diamond Hill Adds Two Companies to Portfolio in Third Quarter

    GuruFocus | Dec. 11, 2014 | 15:19PM EST
  35. Boston Scientific Lost the First Place in Innovation

    GuruFocus | Dec. 11, 2014 | 14:41PM EST
  36. Top 7 Dividend Aristocrats: The Best of The Best

    GuruFocus | Dec. 10, 2014 | 15:05PM EST
  37. Top 4 NYSE Stocks In The Drugs-Generic Industry With The Highest Profit Margin

    Benzinga | Dec. 9, 2014 | 05:09AM EST
  38. 6 Stocks Giving Investors Potential Dividend Hikes In December

    GuruFocus | Dec. 4, 2014 | 13:05PM EST
  39. Fast Money Picks For December 3: Canadian Pacific, Abbott Labs, BlackBerry And Ford

    Benzinga | Dec. 3, 2014 | 07:47AM EST
  40. Jon Najarian Sees Unusual Options Activity In Abbott Laboratories

    Benzinga | Dec. 3, 2014 | 07:31AM EST
  41. Dividend Aristocrats In Focus Part 45: AbbVie

    GuruFocus | Nov. 24, 2014 | 16:13PM EST
  42. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  43. Vipshop Leads 4 Top Stocks With Bolting RS Lines

    IBD | Nov. 18, 2014 | 08:02AM EST
  44. Five Ethical Drugmakers Keep Leadership Positions

    IBD | Nov. 17, 2014 | 18:27PM EST
  45. Benzinga's M&A Chatter for Monday November 17, 2014

    Benzinga | Nov. 17, 2014 | 18:11PM EST
  46. Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal

    IBD | Oct. 31, 2014 | 11:17AM EST
  47. Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Dividend Yield

    Benzinga | Oct. 31, 2014 | 04:59AM EST
  48. Benzinga's M&A Chatter for Wednesday October 29, 2014

    Benzinga | Oct. 29, 2014 | 20:53PM EST
  49. Benzinga's Top Upgrades

    Benzinga | Oct. 29, 2014 | 09:47AM EST
  50. Deutsche Bank Upgrades Abbott Laboratories To Buy

    Benzinga | Oct. 29, 2014 | 08:34AM EST
Trading Center